Latest Minocycline Stories

REHOVOT, Israel, June 11, 2013 /PRNewswire/ -- Foamix, a clinical stage specialty pharma company, has announced today the successful completion of its Minocycline foam Phase II clinical trial. The drug was shown to be highly effective in this double blind, dose ranging, placebo controlled study of 150 moderate to severe acne patients. Once daily treatment of Minocycline Foam 4% exhibited an average 71% reduction in inflammatory lesions after 6 weeks with a respective reduction...

redOrbit Staff & Wire Reports - Your Universe Online An older, broad-spectrum antibiotic has shown “modest” yet meaningful improvements in general behavior, mood and anxiety for children suffering from fragile X syndrome (FXS), claims a study published in this month’s edition of the Journal of Developmental & Behavioral Pediatrics. For the study, researchers from the University of California-Davis Medical Investigation of Neurodevelopmental Disorders (MIND) Institute...

Neurological Wellness Center Patients Report Improved Outcomes with Combination Perispinal Etanercept-Oral Minocycline Therapy; Newly Released Study Identifies Novel Anti-Inflammatory Mechanisms of Minocycline (PRWEB) March 08, 2013 This study, http://onlinelibrary.wiley.com/doi/10.1111/bph.12139/abstract soon to be published in the British Journal of Pharmacology and available now as an abstract online, delineates the mechanisms by which minocycline reduces inflammation. This...

Actor Colin Farrell Celebrates International Angelman Syndrome (AS) Day To Raise Awareness and Funding for AS Specific Research DOWNERS GROVE, Ill., Feb. 13, 2013 /PRNewswire-USNewswire/ -- The Foundation for Angelman Syndrome Therapeutics (FAST) is proud to announce their participation in the 1(st) Annual International Day of Recognition for Angelman Syndrome. On the 15(th) of February, families and friends around the globe will celebrate children affected by Angelman Syndrome and...

An observational study involving 629 subjects finds rapid, significant, readily-observable improvement in stroke and traumatic brain injury patients following the perispinal administration of Enbrel. (PRWEB) January 02, 2013 Neurological Wellness Center began holding perispinal injection technique training courses in the spring of 2011. Since then physicians, nurses and lay caregivers have come from around the world to their Center in Managua Nicaragua for individualized instructional...

The Perispinal Enbrel Injection Procedure that Dramatically Reverses the Cognitive Deficits and Physical Impairments Caused by Alzheimer’s Disease, Stroke and Traumatic Brain Injury is Now Available in a $49 On-Line Course Offered by http://www.neurological-recovery-guide.com (PRWEB) December 19, 2012 Neurological Wellness Center began holding perispinal injection technique training courses in the spring of 2011. Since then physicians, nurses and lay caregivers have come from around...

OTTAWA, April 17, 2012 /PRNewswire/ - Health Canada today released the April 2012 issue of the Canadian Adverse Reaction Newsletter (CARN). This edition contains an article on a suspected association between the long-term use of the antibiotic minocycline for the treatment of acne in adolescents and two serious autoimmune disorders: drug-induced lupus erythematosus (a type of lupus), and autoimmune hepatitis (liver inflammation). It also includes an article on the painkiller...

REHOVOT, Israel, March 14, 2012 /PRNewswire/ -- Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA). The randomized double blind Phase II clinical study, conducted in pediatric patients with impetigo, was designed to assess...

Potential treatment for Angelman Syndrome to be conducted at the University of South Florida DOWNERS GROVE, Ill., Feb. 14, 2012 /PRNewswire-USNewswire/ -- The Foundation for Angelman Syndrome Therapeutics (FAST) announces it will fund a human clinical trial to assess a potential treatment for the rare genetic disorder, Angelman Syndrome (AS). The Minocycline in the Treatment of Angelman Syndrome study will examine if the off label administration of minocycline will alter the...

(Ivanhoe Newswire) -- An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could change the lives of those living with cystic fibrosis.Researchers at McMaster University have discovered this creative approach to tackle antibiotic-resistance to bacterial infections, which is a frequent complication of those with cystic fibrosis. Cystic fibrosis is the most common fatal genetic disease."Antibiotic resistance is having a...